Eton Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
60
Price/Sales ratio
8.40
Earnings per Share (EPS)
$0.27

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-15.24-3.08-7.08-5.92-36.52-7.24-120.00-10.32-21.22
Price/Sales ratio
N/AN/A133.344.37K4.953.333.544.382.19K
Price/Book Value ratio
8.991.4912.1210.906.135.427.257.129.01
Price/Cash Flow ratio
-23.12-4.82-7.09-7.64-22.9014.7016.4819.32-7.36
Price/Free Cash Flow ratio
-22.50-4.68-6.43-7.62-13.5534.8718.5945.81-7.03
Price/Earnings Growth ratio
N/A-0.000.14-0.170.40-0.031.320.02-0.01
Dividend Yield
N/A2.66%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A52.76%-633.33%87.98%67.37%66.56%67.99%-290.28%
Operating Profit Margin
N/AN/A-1939.62%-69515.38%-6.84%-38.86%-3.76%-38.86%-35727.50%
Pretax Profit Margin
N/AN/A-1910.32%-71717.94%-8.95%-42.44%-2.17%-42.44%-36814.13%
Net Profit Margin
N/AN/A-1881.02%-73920.51%-13.56%-46.03%-2.95%-42.44%-37900.76%
Effective Tax Rate
N/A20.27%1.53%-3.07%-51.45%-8.43%-35.84%N/A-1.53%
Return on Assets
-53.23%-44.97%-105.66%-109.53%-10.78%-39.08%-2.94%-36.04%-107.60%
Return On Equity
-58.99%-48.43%-170.98%-184.05%-16.79%-74.79%-6.04%-70.91%-177.52%
Return on Capital Employed
-56.52%-39.23%-123.11%-120.35%-6.52%-44.48%-7.69%-44.48%-121.73%
Liquidity Ratios
Current Ratio
N/A13.587.646.51N/AN/AN/A3.093.25
Quick Ratio
16.7613.587.456.185.053.001.592.815.62
Cash ratio
16.5913.206.145.613.162.521.312.524.38
Days of Sales Outstanding
N/AN/A180.02449.2391.4631.8039.3431.80270.34
Days of Inventory outstanding
N/AN/A306.181.58K76.5329.3231.4229.88830.80
Operating Cycle
N/AN/A486.202.03K168.0061.1370.7737.731.10K
Days of Payables Outstanding
15.13K8.23K463.302.99K246.8592.9763.7494.761.61K
Cash Conversion Cycle
N/AN/A22.90-957.16-78.85-31.847.02-55.58-506.37
Debt Ratios
Debt Ratio
N/AN/A0.260.260.240.250.160.470.26
Debt Equity Ratio
N/AN/A0.430.440.370.490.340.910.43
Long-term Debt to Capitalization
N/AN/A0.300.300.220.29N/A0.290.29
Total Debt to Capitalization
N/AN/A0.300.310.270.320.250.330.30
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-17.91N/A
Cash Flow to Debt Ratio
N/AN/A-3.97-3.17-0.700.751.260.73-3.57
Company Equity Multiplier
1.101.071.611.681.551.912.051.911.64
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-18.79-572.97-0.210.220.210.22-295.88
Free Cash Flow / Operating Cash Flow Ratio
1.021.021.101.001.690.420.880.421.34
Cash Flow Coverage Ratio
N/AN/A-3.97-3.17-0.700.751.260.73-3.57
Short Term Coverage Ratio
N/AN/AN/A-79.80-3.324.661.264.66-37.57
Dividend Payout Ratio
N/A-8.22%N/AN/AN/AN/AN/AN/AN/A